Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296

Strong Performer, Getting Expensive

In 2 Starfolio Baskets

2306.20 -26.70 (-1.14%)

28.65% Gain from 52W Low

10,034

NSE+BSE Volume

NSE 21 Aug, 2026 3:20 PM (IST)

US FDA Approval

Glenmark Pharma gets US FDA nod for nasal allergy spray, targeting a ~$295 million US market See details

Detailed Stock Analysis for Glenmark Pharma with Real-time Stock Report

Download Sample Report